This patient's presentation of painful monocular vision loss with an afferent pupillary defect is classic for optic neuritis, a common presenting symptom of multiple sclerosis (MS). Her previous episode of neurologic symptoms suggests dissemination in time. An acute MS exacerbation causing significant functional disability (in this case, vision loss) is treated with high-dose intravenous corticosteroids (e.g., methylprednisolone) to shorten the duration of the relapse. Oral prednisone is less effective and may increase the risk of recurrent optic neuritis. Interferon beta-1a is a disease-modifying therapy used for long-term management, not acute flares. Plasma exchange is reserved for severe, steroid-refractory relapses.

This patient's clinical presentation demonstrates a combination of both upper motor neuron (UMN) signs (hyperreflexia, Babinski sign) and lower motor neuron (LMN) signs (asymmetric weakness, atrophy, fasciculations). This constellation of findings in a progressive, painless pattern is classic for amyotrophic lateral sclerosis (ALS). Cervical myelopathy can cause mixed UMN/LMN signs but typically involves the neck and may have sensory deficits. Guillain-Barré syndrome is an acute, ascending paralysis, often with areflexia. Myasthenia gravis presents with fluctuating, fatigable weakness, typically affecting ocular and bulbar muscles first, and does not cause UMN signs.

This patient's presentation includes the core features of dementia with Lewy bodies (DLB): fluctuating cognition, visual hallucinations, and parkinsonism. Furthermore, his severe adverse reaction to haloperidol, a typical antipsychotic, demonstrates the classic neuroleptic sensitivity seen in DLB. While Alzheimer's disease can have psychosis, the combination of all these features, especially the fluctuating cognition and profound antipsychotic sensitivity, makes DLB the most likely diagnosis.

The patient's symptoms of leg stiffness, increased tone, and painful spasms are characteristic of spasticity, a common and disabling symptom in multiple sclerosis resulting from upper motor neuron damage. Baclofen, a GABA-B agonist, is a first-line pharmacologic treatment for MS-related spasticity. Tizanidine is another first-line option. Gabapentin is primarily used for neuropathic pain. Amantadine and modafinil are used to treat MS-related fatigue.

Riluzole, a glutamate inhibitor, is the first medication approved for amyotrophic lateral sclerosis (ALS) and has been shown in clinical trials to provide a modest survival benefit, typically extending survival by 2-3 months. It is considered a standard of care for patients with ALS. Edaravone is another approved medication that may slow functional decline in a subset of patients, but riluzole is the classic agent with proven survival benefit. Corticosteroids like prednisone and IVIG are not effective in treating ALS.

Respiratory failure is the most common cause of death in ALS due to progressive weakness of the diaphragm and other respiratory muscles. Noninvasive positive pressure ventilation (NPPV), typically initiated at night when FVC drops below 50% or when symptoms of nocturnal hypoventilation develop, is the standard of care. NPPV has been shown to improve quality of life and prolong survival. Prophylactic tracheostomy is an invasive option considered later. Incentive spirometry is not effective for neuromuscular weakness. Oxygen therapy is not indicated unless hypoxemia is present, and it can worsen hypercapnia from hypoventilation.

The patient's symptoms are characteristic of trigeminal neuralgia, which is a common and often debilitating symptom in patients with multiple sclerosis due to a demyelinating plaque in the trigeminal nerve root entry zone. The first-line treatment for trigeminal neuralgia is carbamazepine, an anticonvulsant that stabilizes neuronal membranes. Oxcarbazepine is also a first-line option. Amitriptyline is a second-line agent. Sumatriptan is for migraine, and propranolol is for migraine prophylaxis or tremor.

This patient presents with severe, longitudinally extensive transverse myelitis (a lesion spanning three or more vertebral segments). While transverse myelitis can occur in multiple sclerosis (MS), the lesions are typically shorter. The combination of a longitudinally extensive lesion, a normal brain MRI, and negative CSF oligoclonal bands is highly suggestive of Neuromyelitis Optica Spectrum Disorder (NMOSD), an autoimmune condition often associated with antibodies against aquaporin-4. Distinguishing NMOSD from MS is critical as treatments differ significantly.

When a patient lacks decision-making capacity and has no advance directive, the healthcare proxy should make decisions based on the principle of substituted judgment—what the patient would have wanted for herself. The physician's role is to guide the proxy in this process. Instead of immediately imposing a recommendation or blindly following the initial emotional request, the most appropriate step is to explore the patient's values, beliefs, and previously expressed wishes with the daughter. This patient-centered approach helps the proxy make a decision that truly honors the patient, rather than one based on guilt or misunderstanding.

This patient has an isolated, progressive language disorder (primary progressive aphasia, PPA). His symptoms of effortful, halting speech with sound errors (phonemic paraphasias) and incorrect grammar (agrammatism), in the setting of preserved comprehension and memory, are the hallmark features of the nonfluent/agrammatic variant of PPA. This is a form of frontotemporal lobar degeneration. Logopenic PPA is characterized by word-finding difficulty and impaired repetition (often associated with Alzheimer's pathology). Semantic variant PPA involves loss of word meaning.